Interestingly 15% of the company is now to be handed out to insiders ,of course their patience and support must be rewarded . Difficult times are in the past and the formation of a new company will shoot this under -performer skyward .
The patents alone will be worth more than a small profitable company and I expect a £10 million valuation is not too long in the future .
A good result in the current court case and future demand for Biomerics and St Jude will continue this share on the road to recovery . Good times lay ahead , don`t miss the boat .